Reddit Posts
I’m new to this, does anyone think ATAI has possible short squeeze potential?
20 APRIL 2026, WHAT ARE THE BIGGEST WINNERS PRE-MARKET AN WHY ?
Trump just signed an EO to fast-track psychedelics. ATAI ($1.4B) and GHRS ($1.04B) are Phase 3-ready with FDA Breakthrough designations.
BREAKING: Trump signing Ibogaine Executive Order this week here's why ATAI, PBM, CMND, ENVB, MNMD are the plays
BREAKING: Trump signing Ibogaine Executive Order this week here's why ATAI, PBM, CMND, ENVB, MNMD are the plays
5 Penny Stocks That Might Be About to Take Off
Profitable after almost 6 years. -56k comeback.
These Anxiety pills will be as popular as Aspirin
AtaiBeckley Is Said to Explore Options for Main Psychedelic Drug
AtaiBeckley Announces Successful End-of-Phase 2 Meeting for BPL-003 in Treatment-Resistant Depression
AtaiBeckley Announces Successful End-of-Phase 2 Meeting for BPL-003 in Treatment-Resistant Depression
AtaiBeckley Announces Positive Topline Results from an Exploratory Phase 2a Trial of EMP-01 (oral R-MDMA) in Social Anxiety Disorder
🚨 Billionaire Backed Biotech Going After Treatment Resistant Depression $ATAI
Recent update from $ATAI
$ CMPS! once in a decade opportunity with a product that will change the whole field of psychiatry or better yet hopefully change the world.
$ATAI and the new approach to curing depression
AtaiBeckley $ATAI Provides Update and Outlook for 2026
The Psychedelic Merger: Inside AtaiBeckley's Rise ($ATAI Stock)
Psychedelic portfolio out performing general markets and tech check out MNMD and ATAI
Posted ATAI yesterday, up 15% today. hope some of you joined 🚀
My $4,000 penny stock mix - Open, CMPS, SCWO, YYAI, ATAI & DVL
ATAI ~ If FDA approved DMT doesn’t save us, nothing will
ATAI ~ If FDA-Approved DMT Doesn’t Save Us, Nothing Will
ATAI ~ If FDA Approved DMT Doesn’t Save Us, Nothing Will
ATAI Life Sciences - Expecting Positive FDA Movement Soon
ATAI is setting up for a fat dump. Don’t fall for the bounce
💊 MNMD & ATAI — Psychedelics Are About to Make “MAHA”
Bullish News for Psychadelic Stocks? "FDA Issues First Draft Guidance on Clinical Trials with Psychedelic Drugs..."
Special Situations for Thursday: $DSS, $ATAI, $MIGI, $BIOL
Special Situations for Thursday: $DSS, $ATAI, $MIGI, $BIOL
Atai stock rises amid restructuring with ~30% job cuts (NASDAQ:ATAI)
Mexican Senator To File Psychedelics Legalization Bill, With U.S. Congressman Backing International Reform Push
What's your opinion on ATAI and other psychedelic medicine companies?
Unlock The Mind - Solving America's Mental Health Crisis with $ATAI (Atai Life Sciences). Full DD on the Psychedelic sector potential. 🍄
Unlock The Mind - Solving America's Mental Health Crisis with $ATAI (Atai Life Sciences) Full DD on the Psychedelic sector potential. 🍄 DD
A Look at "R-Ketamine" Drug Development Ahead of $ATAI's PCN-101 Phase 2a December 2022 Data Readout (Psychedelic Stock)
ATAI Life Sciences what do you guys think?
What is your opinion on small cap biotech stocks like TSHA and ATAI?
ATAI, A Company with a lot of potential for short term and long-term gains.
What’s your favorite Magic Mushroom Penny Stock? A few I’ve been looking into are FTRP, SEEL, CYBN, CMPS, GHRS, ATAI, MNMD.
Cathie Wood makes her first investment in Psychedelics
$IGXT Due Diligence - Not your average biotech play. Dissolvable Oral films with medicine on them, faster onset, compliance, skip first pass digestion (similar to injections).
The Upcoming Psychedelic Sector Opportunity 🍄 (FDA Phase 2b data readout in November 2021)
The Upcoming Psychedelics Sector #ShroomBoom 🍄 (November 2021 FDA Phase 2b Catalyst)
$IGXT Up 43% in the last four trading sessions despite heavy short volume
Update On $IGXT since my last post, up about 41% since.
$IGXT Patient Screening to Resume in IntelGenx’s ‘BUENA’ Montelukast VersaFilm® Phase 2a Clinical Trial in Patients with Mild to Moderate Alzheimer’s Disease.
$IGXT; Pennystock that has turned the corner and gone from R&D to Manufacturing. Oral film Delivery system (Oral films that go directly to bloodstream, Skip first pass digestion). The market hasn't caught onto this company yet..
IntelGenx Receives U.S.$6 Million in Additional Loans from atai Life Sciences and Conditional Approval to Graduate to Toronto Stock Exchange!!!
$ATAI psychedelics getting ready to go apeshit.
IntelgenX officially launches Rizaport in spain!!
Mentions
This is a dumb enough conclusion for me to understand. ATAI looks really interesting.
Psychedelics will make the next ones this year. Look at $DFTX $ATAI and $CMPS
ATAI - psychedelic antidepressant. Because I've seen really serious depression devastate someone, and I've never had a bad trip, so what could go erong. LODE - recycling silver out of old solar panels Because silver is expensive, digging mines is tedious, might as well mine solar panels. Eutelsat - LEO satellites that compete (barely) with Starlink. Because Elon doesn't own it and the Europeans are bound to get it together eventually.
ATAI giving away several $20,000 grants I guess. Bullish 🐥
ATAI or one of those stocks that can relieve people's depression and PTSD, maybe.
I have small position in ATAI and it's green. Let's see what the future brings
are people bullish on ATAI??
Yes — ATAI could experience a short squeeze, but based on the current data it looks more like a moderate squeeze setup, not a guaranteed “massive squeeze” setup. ATAI is trading around $4.20, with roughly 6.99M shares traded intraday in the latest market data. Current reported short interest is about 26.17M shares, or roughly 8.6%–9.8% of the float, depending on the source’s float calculation. Days-to-cover estimates range from about 6.35 to 8.8 days, which is meaningful because it suggests shorts could need multiple trading days to fully cover if buying pressure spikes. The reason ATAI has squeeze potential is that it has three ingredients: elevated short interest, a biotech catalyst calendar, and a stock that can move fast on news. The big catalyst is BPL-003, which ATAI says remains on track to begin two parallel Phase 3 studies in Q2 2026 after a successful End-of-Phase 2 FDA meeting; BPL-003 also has Breakthrough Therapy Designation. Positive updates around Phase 3 initiation, financing, partnership news, analyst upgrades, or strong sector momentum could force some shorts to cover. That said, ATAI’s short interest is not extreme. A really explosive squeeze usually has short interest well above 20%–30% of float, limited borrow availability, high borrow fees, and sudden volume far above normal. ATAI’s short interest around 9% of float is enough to add fuel to a rally, but not enough by itself to guarantee a violent squeeze. Fintel also shows a low borrow rate around 0.5%, which suggests shorts are not currently under major borrowing-cost pressure. My read: a squeeze is possible if ATAI gets a strong catalyst and volume ramps hard, but the more likely scenario is a catalyst-driven biotech rally with short-covering as an accelerant, rather than a pure meme-style short squeeze.
What do you think about ATAI?
I bought ATAI. Will be $10+ by end of year.
Buying ATAI at peak and losing 80% in 1 day later might be the worst trade I ever made
With ATAI you don't need talk therapy, with CMPS you do
ATAI is developing BPL-003 which takre an hour for treatment. CMPS is developing COMP360 which takes 6-8 hours. ATAI also has stakes in several other companies and molecules I the same space. Right now CMPS market cap is 1.2b, ATAI 1.6b. CMPS already ran it's price up on the NPV news, ATAI did not get a voucher so still has significant room to run imho.
It ran up 40% before the voucher was even promised to them. I see it consolidating and flying as this progresses. I also like Atai too. CMPS and ATAI are the only psych stocks I own.
ATAI has twice the market cap of CMPS for a similar product and identical target demographic?
That's true, but CMPS ran up like 40% on the voucher news. ATAI has more molecules in the pipeline with significantly quicker acting effects. CMPS is also now facing direct competition from non-profit Osana Institute which also received an NPV for psilocybin. FWIW I love CMPS and am loading up on them as well.
ATAI is more undervalued at the moment IMO.
ATAI is gonna rip hard after this mini pullback. they got drugs for sale
Seastar Medical (ICU): revolutionary technology to treat a common problem (it’s like a dialysis machine for your inflammation cells). Already approved for pediatrics. Will bump again when approved for adults, trial currently undergoing Otherwise psychedelics: ATAI, CMPS, DFTX
Not a penny stock but ATAI is a big player in this industry and is way undervalued compared to its competitors.
Solid basket mentioned by SnozzberryBoom (CMPS, HELP, ATAI, DFTX) plus the three you listed. Thing to watch with FDA-fast-track news on psychedelics is the gap between headline and actual IND submissions - the larger names (CMPS especially) tend to hold their gains on these catalysts while the smaller OTC ones often give most of it back within a couple weeks once volume fades. CMND is interesting because the Israel-based trials tend to run faster than US so there should be real data flow by Q3. Position sizing matters way more than picking on these, I usually cap single psychedelic names at 2% portfolio because the clinical-readout outcome distribution is bimodal and ugly.
My CMPS and ATAI calls are printing
About time. Using the Right to Try Act for ibogaine is a game changer for the veteran community. Keeping an eye on $ATAI now that they’ve merged with Beckley, they have the deepest pockets in the sector.
HELP, CMPS, DFTX, ATAI are all major players in the industry
Is it just me, or is the sentiment on ATAI stuck in 2022? The company has rebranded, the pipeline has matured, and the political tailwinds are strong. I’ve tried searching this subreddit for topics on ATAI Life Sciences (ATAI Beckley), but only found a couple of thread, years old. I think recent events warrant a new thread. Quick recap: ATAI Life Sciences is doing research into Mebufotenin benzoate, DMT, R-MDMA and Novel 5-HT2A Receptor Agonists. They aren’t just "theorizing" anymore. BPL-003 is hitting Phase 3, and their R-MDMA trials are yielding actual, promising results for mental health. I for one am a great believer in the medicinal applications of some of these substances. I think anyone who has ever used them would feel the same way, but we finally have the peer-reviewed data to back it up. The only reason these drugs aren’t yet being used for medical purposes on a massive scale is because Richard Nixon’s war on drugs killed any if not all interest before scientists could do serious research back in teh 70’s. We are now finally witnessing the release of that oppression. With Trump’s recent executive order to speed up psychedlic research, stocks like ATAI have seen a massive spike. Why do you think this ticker gets zero oxygen here? Is the stigma still that strong, or are people waiting for the Phase 3 readout before they jump in? [ATAI Pipeline](https://www.ataibeckley.com/our-work/pipeline) [Trump Executive Order](https://www.whitehouse.gov/fact-sheets/2026/04/fact-sheet-president-donald-j-trump-is-accelerating-medical-treatments-for-serious-mental-illness/)
VM what’s ATAI doing?
Once again, should've just taken the exit liquidity on ATAI life sciences.
I do long calls on bio stocks that I like but don't love and my CMPS was up 1500%today haha. ATAI up 400%
DFTX,CMPS,ATAI- top psychedelic stocks
Lost a grand on ATAI today
Dammit. I have ATAI, I didn’t know the Thiel connection.
Bro you seeing CMPS and ATAI?
Awful day for me to be a bear. If I werent such a bear my portfolio would be 25% EOSE, INV, ATAI. Sad noises seeing that basket up over 15% today on average
Psychedelics stocks went crazy-->CMPS, HELP, DFTX, ATAI
Phase 3 trials in CMPS and soon for ATAI.... People comparing to tilray have no idea
Well yeah, thats why i bought ATAI last fall I saw the writing on the wall for psychedelics. Now look at UMAC
Was just about to comment on ATAI. Shit’s rippin!
My Roth is getting so high off its own (psychedelic) supply CPMS, ATAI, DFTX
History tells me to just take the exit liquidity on ATAI life sciences.
Finally closed my ATAI calls a couple weeks ago because I’m too impatient for real LEAPs and hate money.
Anyone who thinks the psychedelic stocks are pump and dumps don’t know how much upside these stocks have. Of course there’s a good amount of risk but if you do your research and choose a winner it can be a 10x no doubt. $CMPS my favorite, $ATAI second best, $PBM solid too. There are a lot of others too I haven’t looked as closely into those.
DFTX, ATAI, CMPS. Trumps execute order has them blowing up
Mainly DFTX but a little ATAI as well
No, the real pump is in psychedelics right now. Check out ATAI CMPS
ATAI ripper CMPS ripper
Look at ATAI look at CMPS, shrooms bout to run so hard
Thiel is in CMPS and ATAI
Of all of them, Compass Pathways has the most recently completed compiled and published phase 3 data at 26 week endpoint with successful numbers (something like 76% of treatment resistant, depression patients in full remission 6 months after a single treatment or two treatments). They already announced in an earlier press release this year that they are on track for commercialization in 2027 and planned on a rolling NDA submission this year with the FDA in Q4. ATAI has the most drug variants in the pipeline, but CMPS is set to be first across the line
Well psychedelics got an Executive Order to move forward and DFTX, ATAI and CMPS will likely go brrrrrrrr
DFTX, ATAI, CMPS... those are the three unicorns here.
Anybody interested in getting in on this should check out r/shroomstocks. Long-standing community with a lot of good news/info and discussion. As with any subreddit, plenty of bad info too, so up to you to be discerning. There are only a handful of standout companies in this space: CMPS (psilocybin for treatment resistant depression) - finished second phase 3 trial with positive data, submitting NDA later this year, widely expected to receive an FDA priority voucher next week..also starting phase 3 trial for PTSD this quarter DFTX (LSD for major depressive disorder and general anxiety disorder) - has three phase 3 trials concluding this year and not far behind CMPS in terms of timeline to approval, also generally expected to get a voucher this week ATAI (namely 5-Memo-DMT for TRD, as well as 2-3 other psychedelic molecules in trial) - beginning first phase 3 trial of their main drug this quarter I believe HELP (deuterated psilocin for MDD…and N,N-DMT for GAD) - phase 3 data from psilocin trial coming Q4 2026
This was not baked in on Thursday at all. $CMPS, $ATAI, $HELP and Definium will all benefit
Psychedelic stocks. ATAI. CMPS. GHRS. CYBN. MNMD. I'm in none of them and we should have been in them Friday, but here you go.
**Compass Pathways (CMPS):** A major player in the space, they are in Phase 3 trials for **psilocybin therapy** (COMP360) for treatment-resistant depression. Despite some previous regulatory friction, they are a primary candidate for the FDA's new "priority vouchers" mentioned in the order. **AtaiBeckley (ATAI):** Formed through the merger of Atai Life Sciences and Beckley Psytech, this company is researching several compounds, including **5-MeO-DMT** and **ibogaine** derivatives. Their stock saw significant movement following the announcement. **Beond, Inc.:** A U.S.-based company specializing in **ibogaine-assisted therapies**. They recently established a headquarters in Austin, Texas, and issued a statement confirming their intent to provide the "gold-standard" clinical model for the research framework established by the order. **Helus Pharma (formerly Cybin):** Recently rebranded in early 2026, Helus is advancing HLP003 (a proprietary psilocybin analog) through two pivotal Phase 3 studies. They already hold an FDA Breakthrough Therapy Designation, making them a direct beneficiary of the order's mandate to "dramatically accelerate" access. **Definium Therapeutics & Psyence Biomedical:** Both companies are actively conducting research on psychedelic-derived treatments for mental health and were highlighted by market analysts as key entities affected by the administration's policy shift.
ATAI raises capital through CMPS shares. They are down to around a ~5% stake.
ATAI- trump just signed psychedelics bill
Sure, cuz his and Thiels buddies are heavily invested in ATAI etc
I love that I posted this months ago and the retards in here said you could get shrooms behind a dumpster. Can’t wait to them to landscape my lawn. Long $CMPS $ATAI
ATAI also has a large position in CMPS. So an investment in ATAI gives you exposure to both.
CMPS got to Phase 3 first but “further along” isn’t “better positioned.” The killer issue is treatment duration. CMPS psilocybin requires 4-6 hours of supervised clinic time. GHRS GH001 takes ~11 minutes, discharge-ready within 1 hour. That’s 8-10 patients per chair per day vs 2. Payers and clinic operators will do that math real fast. The data also isn’t close. GH001 Phase 2b showed -15.5 point MADRS reduction vs placebo with 57.5% remission at Day 8 and zero serious adverse events. CMPS COMP360 had fading efficacy by week 12 and suicidal ideation flags. GHRS published in JAMA Psychiatry. Sell-side: 9/9 Buy on GHRS, 14/14 Buy on ATAI. CMPS consensus is mixed. I’d rather own the best data entering Phase 3 than the worst data already in Phase 3.
#TLDR --- Ticker: ATAI & GHRS Direction: Up 🚀 (Across the astral plane) Prognosis: Buy Shares and ATAI Jan 2027 Calls Catalyst: Trump, RFK Jr., and Joe Rogan literally teaming up in the Oval Office to fast-track FDA approval for psychedelics. Vibe: Make America Trip Again 🍄🦅
#TLDR --- Ticker: ATAI & GHRS Direction: Up 🚀 (Straight to the astral plane) Prognosis: Buy shares or ATAI Jan 2027 Calls Catalyst: Trump, RFK Jr., and Joe Rogan teaming up in the Oval Office to fast-track DMT Side Effects: Your portfolio might start seeing colors and curing its own depression
ATAI going to rip on Monday https://www.cnn.com/2026/04/18/politics/trump-signs-executive-order-urging-more-research-into-psychedelic-ibogaine
$ATAI Think Peter Thiel owns this one
The best current reporting says the White House is **drafting** an order and that Trump **intends to sign it as soon as this week**. That is not the same as a signed, published order. On the substance question, the current reporting points to **ibogaine** as the main focus of the proposed order. ATAI is the best choice because it has **real ibogaine exposure through IBX-210** while also being a **larger, more diversified psychedelic biotech**, so you are not relying on just one speculative headline. It is a cleaner, more durable way to play ibogaine than tiny momentum names like PBM, which are more vulnerable to sharp reversals. \+ its chart looks more stable
ATAI up today bc 🥭 signed a bill that lets drugs be used in therapy or something
Whats ATAI doing? News?
Own 2 of those, currently; and I'm already up 90% on DNN at the moment. Gonna hold. Gonna hold ATAI, too. I think the "shroom" psychiatric market might explode soon. If not? Well, penny stocks are just gambling, anyway. Don't place all your eggs and whatnot.
Ive been in on ATAI for a while now. One addition, they are actively seeking a major pharmaceutical company for partnership on their leading drug candidate right as is about to enter Phase 3. If that lands this could jump quick.
ZENA, PCT, ATAI, TELO are my top 4 primed
Psychedelic therapeutic stocks, ATAI and CMPS also doing well past year after taking big dumps post IPO. Lots of trials in the works and potential for big boys to scoop them up.
DFTX is currently the most overbought stock in this industry. I'm much more bullish on ATAI personally
Psyence and ATAI both have ibogaine treatments in their pipeline.
ATAI. Best-in-class psychadelic biotech company.
I bailed on a lot of speculative stuff (aka stuff I heard about on Reddit) but am holding on to the ones I believe in. Biggest position is 8k shares of ATAI. Down $3k now, should have taken profits this fall when it was up $14k 🤦♂️🤦♂️. I learned a LOT about investing and trading this past year so it hasn’t been all bad. It’ll all come back, learning to be patient.
All this craziness makes me keep buying psychedelic stocks. The amount of PSTD, Anxiety and Depression is insane. Only the serious players though (because there is a lot of crap).... DFTX and ATAI for the win.
Oddly my psychedelic plays are doing good. DFTX and ATAI. All things considered.
Look into ATAI. Possibly my greatest find yet. Backed by a couple of powerful tech billionaires. It’s going to go nuclear.
Glad to see ATAI on there.
My view, there are two companies with more advanced pipeline. CMPS will likely be approved this year and ATAI is 2-3 years behind.
$ATAI NEWS Shares of drugmaker AtaiBeckley ATAI.O rise 1.29% to $3.94 premarket ** Co says its experimental depression drug BPL‑003 will enter late‑stage testing in Q2 2026 after positive FDA feedback ** Says BPL‑003 is aimed at treatment‑resistant depression, a severe form of the condition where common therapies do not work ** Adds nasal‑spray drug showed rapid, lasting benefit in mid‑stage study, with effects seen in two days and lasting up to eight weeks ** Two upcoming 12‑week trials, plus a year‑long extension, will test the drug against placebo - ATAI ** Co reaffirms cash runway into early 2029 and reports progress on anxiety drug EMP‑01 and depression drug VLS‑01 ** ATAI rose about three-fold in 2025
Is it finally time to dump ATAI for good? The PT of $14 followed immediately by the offering...
ATAI is gonna pop tomorrow
ATAI is supposed to pop off I heard
# ATAI. This news just came out: [https://ir.ataibeckley.com/news-releases/news-release-details/ataibeckley-announces-successful-end-phase-2-meeting-bpl-003](https://ir.ataibeckley.com/news-releases/news-release-details/ataibeckley-announces-successful-end-phase-2-meeting-bpl-003)
ATAI is getting ready to pop 🚀
>He also said they did see improvement in social anxiety, about on par with existing treatments Normally this would ruin chances of FDA approval. However, ATAI's focus is on *treatment-resistant* depression and anxiety. So as long as its psychedelic pipeline works (and traditional SSRIs don't), it meets the required use case - and investors sell-off was overblown. I exited ATAI in early October but will trim both SLS and ABOS profits to buy back in.
Wow wtf is happening with ATAI. This stock never stops fucking me.